Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients.

Trial Profile

Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Doripenem (Primary)
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Acronyms Dori-MD-ICU
  • Most Recent Events

    • 18 Oct 2014 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
    • 18 Oct 2014 Planned number of patients changed from 16 to 20, according to European Clinical Trials Database record.
    • 06 Sep 2011 Planned end date (Jul 2013) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top